JUL 07, 2016 4:11 PM PDT

Integrated Genomic and Proteomic Approach for Ovarian Cancer

WRITTEN BY: Cassidy Reich
Ovarian cancer accounts for 3% of all cancers among women and is the 5th leading cause of cancer deaths for women in the U.S. The most aggressive form of ovarian cancer, the high-grade serous carcinoma (HGSC), accounts for 70% of ovarian cancer cases. Only 1 in 6 patients lives 5 or more years after diagnosis with an HGSC.

                 Ovarian cancer is the 5th leading cause of cancer death among women.
A very innovative, collaborative effort between groups at Johns Hopkins and the Pacific Northwest National Laboratory combined genomic and proteomic data from a total of 169 ovarian tumors. This approach is so innovative because cancer is usually considered a disease of the genome, with mutated genes being expressed as oncogenic, dysfunctional proteins. However, looking at complete profile of expressed proteins, known as the proteome, provides even more insights into disease pathology than just looking at the genome.

The Johns Hopkins team analyzed a set of ovarian tumor samples that had previously sequenced by The Cancer Genome Atlas (TCGA) that they chose based on their degree of homologous recombination deficiency and characterized by mutations in BRCA1, BRCA2, or PTEN. Mutations in these genes is also well-known to cause breast cancer, as well as increase cancer risk and severity. By looking at ovarian tumors with the same mutations as some breast cancers, the researchers were hoping to find enough similarities in the functional proteomes of these two cancers to open the door to the possibility of ovarian cancer patients receiving the same drug regimen that breast cancer patients have.

The other team in the study based at Pacific Northwest National Laboratory looked at another set of ovarian tumors that had also been sequenced by TCGA. Instead of looking at samples with certain mutations or deficiencies, their strategy was to search for biological factors that could contribute to survival time.

Using mass spectrometry, the two teams identified 3586 proteins common to all of the 169 tumors analyzed. Sifting through all these proteins was obviously a massive undertaking, but it provided many novel insights into the aggressive HGSC. A characteristic of cancer in general, but particularly of HGSCs, is the appearance of copy-number variations. Through this massive proteogenomic experiment, the two teams identified sections of chromosome 2, 7, 20, and 22 that were prone to increased copy-number and lead to increased expression of more than 200 proteins. Many of these overexpressed proteins are involved in cell movement and immune system function; both of the processes are very connected to cancer progression.

The researchers also saw that the very diverse genome rearrangements of the different samples converged on similar signaling pathways. And for the main goal of the team from Pacific Northwest National Laboratory, they were able to identify certain signaling pathways that were associated with short survival. These results would not have been possible to find by just looking at the genome, proving the importance of the proteome in cancer research.

Sources: EurekAlert and Cell
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
MAR 02, 2021
Cell & Molecular Biology
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
MAR 02, 2021
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
Retroviruses can infect cells and insert themselves into the genetic code of their host. Sometime in the past 50,000 yea ...
MAR 02, 2021
Cancer
New tissue restoration technology could help breast cancer patients
MAR 02, 2021
New tissue restoration technology could help breast cancer patients
New work published in Scientific Reports describes the development of an in situ scaffold-forming collagen that cou ...
MAR 03, 2021
Cancer
Multiple breast cancer screenings reduce mortality rates
MAR 03, 2021
Multiple breast cancer screenings reduce mortality rates
New research published in the journal Radiology reports on the advantages that multiple breast cancer screenings can hav ...
MAR 05, 2021
Cancer
Can bone marrow recover post-chemotherapy?
MAR 05, 2021
Can bone marrow recover post-chemotherapy?
New research stemming from Osaka University reports identifying the mechanism by which hematopoietic stem and progenitor ...
MAR 15, 2021
Cell & Molecular Biology
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
MAR 15, 2021
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
Cells are packed full of organelles and molecules like proteins floating in a liquid known as cytoplasm. In recent years ...
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
Loading Comments...